Diffusion of breast cancer risk assessment in primary care
- PMID: 19429733
- PMCID: PMC2882882
- DOI: 10.3122/jabfm.2009.03.080153
Diffusion of breast cancer risk assessment in primary care
Abstract
Background: Physicians who provide primary care to women have the opportunity to identify patients at high risk for breast cancer who are candidates for risk reduction strategies. Our objective was to determine the prevalence and determinants of the adoption of breast cancer risk assessment by primary care physicians.
Methods: A cross-sectional survey of a nationally representative random sample of 351 internists, family practitioners, and obstetricians-gynecologists. We used a questionnaire that assessed knowledge, attitudes, discussion of breast cancer risk, use of software to calculate breast cancer risk, and ordering of BRCA1/2 testing.
Results: Eighty-eight percent of physicians reported discussing breast cancer risk at least once during the previous 12 months; 48% had ordered or referred a patient for BRCA1/2 testing; and 18% had used a software program to calculate breast cancer risk. Physicians who had used BRCA1/2 testing or discussed breast cancer risk factors were more likely to be obstetrician-gynecologists and not in a solo practice; the use of risk software was also more common among obstetrician-gynecologists but was also associated with having a family member with breast cancer and a greater knowledge about breast cancer risk. Having patients ask for risk information was associated with the discussion of risk factors but not with the other risk assessment strategies.
Conclusions: Diffusion of breast cancer risk assessment is occurring in primary care practices, with a greater adoption of BRCA1/2 testing than of the use of risk assessment software. Adoption of these strategies seems to be related to the salience of breast cancer personally (for the physician) and within the practice, as well as the size of the practice, rather than attitudes about the risk assessment methods.
Conflict of interest statement
None of the authors has a financial conflict of interest related to the subject of the study.
Similar articles
-
Specialty differences and the ordering of screening mammography by primary care physicians.J Am Board Fam Pract. 1994 Sep-Oct;7(5):375-86. J Am Board Fam Pract. 1994. PMID: 7810354
-
Screening and intervention for intimate partner abuse: practices and attitudes of primary care physicians.JAMA. 1999 Aug 4;282(5):468-74. doi: 10.1001/jama.282.5.468. JAMA. 1999. PMID: 10442663
-
Influence of obstetric practice on workload and practice patterns of family physicians and obstetrician-gynecologists.Ann Fam Med. 2008 Jan-Feb;6 Suppl 1(Suppl 1):S5-11. doi: 10.1370/afm.737. Ann Fam Med. 2008. PMID: 18195307 Free PMC article.
-
Sex differences among obstetrician-gynecologists: a review of survey studies.Obstet Gynecol Surv. 2013 Mar;68(3):235-53. doi: 10.1097/OGX.0b013e318286f0aa. Obstet Gynecol Surv. 2013. PMID: 23945840 Review.
-
Breast cancer risk evaluation for the primary care physician.Cleve Clin J Med. 2022 Mar 1;89(3):139-146. doi: 10.3949/ccjm.89a.21023. Cleve Clin J Med. 2022. PMID: 35232826 Review.
Cited by
-
Impact of Affordable Care Act Provisions on the Racial Makeup of Patients Enrolled at a Deep South, High-Risk Breast Cancer Clinic.J Racial Ethn Health Disparities. 2024 Sep 5. doi: 10.1007/s40615-024-02104-y. Online ahead of print. J Racial Ethn Health Disparities. 2024. PMID: 39235712
-
Talking numbers: how women and providers use risk scores during and after risk counseling - a qualitative investigation from the NRG Oncology/NSABP DMP-1 study.BMJ Open. 2023 Nov 19;13(11):e073138. doi: 10.1136/bmjopen-2023-073138. BMJ Open. 2023. PMID: 37984961 Free PMC article. Clinical Trial.
-
Determinants of guideline-concordant breast cancer screening by family physicians for women aged 40-49 years: a qualitative analysis.CMAJ Open. 2022 Oct 18;10(4):E900-E910. doi: 10.9778/cmajo.20210266. Print 2022 Sep-Oct. CMAJ Open. 2022. PMID: 36257683 Free PMC article.
-
Pilot study of a culturally sensitive intervention to promote genetic counseling for breast cancer risk.BMC Health Serv Res. 2022 Jun 25;22(1):826. doi: 10.1186/s12913-022-08193-x. BMC Health Serv Res. 2022. PMID: 35752812 Free PMC article.
-
Healthcare Predictors of Information Dissemination About Genetic Risks.Cancer Control. 2022 Jan-Dec;29:10732748221104666. doi: 10.1177/10732748221104666. Cancer Control. 2022. PMID: 35658635 Free PMC article.
References
-
- Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin. 2007;57(1):43–66. - PubMed
-
- Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2003. Bethesda, MD: National Cancer Institute; 2006.
-
- Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879–86. - PubMed
-
- Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. N Engl J Med. 2000;342:564–71. - PubMed
-
- Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. N Engl J Med. 2000;342(8):564–71. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous